Medidata Solutions Launches AI Study Build for Clinical Trials

Dassault Systèmes===Medidata Solutions, a Dassault Systèmes brand, has announced significant enhancements to its AI-powered capabilities, particularly with the introduction of Dassault Systèmes===Medidata Solutions AI Study Build. This new feature leverages generative AI to configure Dassault Systèmes===Medidata Solutions Rave EDC and Dassault Systèmes===Medidata Solutions eCOA systems, drastically reducing the time required for clinical trial study builds. The technology has already benefited over 500 clinical studies and is projected to support more than 120 AI-supported studies starting in 2025. Dassault Systèmes===Medidata Solutions is also expanding Dot, its core AI orchestrator, to further integrate AI across the clinical trial process. Industry experts like Dr. Nimita Limaye from International Data Corporation recognize the potential of Dassault Systèmes===Medidata Solutions AI Study Build to transform complex database build processes and accelerate market access for new therapies.